SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Acquisitions
24. Oktober 2019 13:59 ET
|
Rigrodsky & Long, P.A.
WILMINGTON, Del., Oct. 24, 2019 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating: Achillion Pharmaceuticals, Inc. (NASDAQ GS: ACHN) regarding possible breaches of...
PGNX, PRTO, and ARTX SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Mergers
17. Oktober 2019 13:58 ET
|
Rigrodsky & Long, P.A.
WILMINGTON, Del., Oct. 17, 2019 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating: Progenics Pharmaceuticals, Inc. (NASDAQ GS: PGNX) regarding possible breaches of...
HLND, UCFC, and TRCB SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Mergers
26. September 2019 13:37 ET
|
Rigrodsky & Long, P.A.
WILMINGTON, Del., Sept. 26, 2019 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating: Proteon Therapeutics, Inc. (NASDAQ GS: PRTO) regarding possible breaches of...
Proteon Therapeutics Announces the Closing of Initial Public Offering and the Underwriters' Option to Purchase Additional Shares
24. November 2014 08:00 ET
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., Nov. 24, 2014 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with...